9,007
Total Claims
$700K
Drug Cost
1,132
Beneficiaries
$619
Cost/Patient
Peer Comparison vs. 7,389 General Practice providers
-45%
Cost per patient vs peers
$619 vs $1,128 avg
+76%
Brand preference vs peers
14.8% vs 8.4% avg
Brand vs Generic
85% generic
Brand: 1,318 claims · $596K
Generic: 7,567 claims · $100K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 182 | $132K |
| Bictegrav/Emtricit/Tenofov Ala | 19 | $75K |
| Apixaban | 33 | $45K |
| Insulin Nph Hum/Reg Insulin Hm | 133 | $34K |
| Insulin Aspart | 38 | $30K |
| Sacubitril/Valsartan | 18 | $27K |
| Rivaroxaban | 19 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $14K |
| Atorvastatin Calcium | 921 | $12K |
| Insulin Detemir | 17 | $9,493 |
| Insulin Nph Hum/Reg Insulin Hm | 22 | $9,050 |
| Albuterol Sulfate | 268 | $8,607 |
| Budesonide/Formoterol Fumarate | 15 | $8,266 |
| Losartan Potassium | 423 | $5,275 |
| Brimonidine Tartrate/Timolol | 13 | $4,861 |
Prescribing Profile
93
Unique Drugs
$254K
Patient Profile
71
Avg Age
50%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data